Privacy Policy for http://mesotheliomacancertreatmentoptions.blogspot.com

If you require any more information or have any questions about our privacy policy, please feel free to contact us by email at shafprince@gmail.com. 

At http://mesotheliomacancertreatmentoptions.blogspot.com, the privacy of our visitors is of extreme importance to us. This privacy policy document outlines the types of personal information is received and collected by http://mesotheliomacancertreatmentoptions.blogspot.com and how it is used. 

Log Files
Like many other Web sites, http://mesotheliomacancertreatmentoptions.blogspot.com makes use of log files. The information inside the log files includes internet protocol ( IP ) addresses, type of browser, Internet Service Provider ( ISP ), date/time stamp, referring/exit pages, and number of clicks to analyze trends, administer the site, track user’s movement around the site, and gather demographic information. IP addresses, and other such information are not linked to any information that is personally identifiable. 

Cookies and Web Beacons 
http://mesotheliomacancertreatmentoptions.blogspot.com does use cookies to store information about visitors preferences, record user-specific information on which pages the user access or visit, customize Web page content based on visitors browser type or other information that the visitor sends via their browser. 

DoubleClick DART Cookie 
.:: Google, as a third party vendor, uses cookies to serve ads on your site.
.:: Google's use of the DART cookie enables it to serve ads to your users based on their visit to your sites and other sites on the Internet. 
.:: Users may opt out of the use of the DART cookie by visiting the Google ad and content network privacy policy at the following URL - http://www.google.com/privacy_ads.html 

Some of our advertising partners may use cookies and web beacons on our site. Our advertising partners include ....
Google Adsense


These third-party ad servers or ad networks use technology to the advertisements and links that appear on http://mesotheliomacancertreatmentoptions.blogspot.com send directly to your browsers. They automatically receive your IP address when this occurs. Other technologies ( such as cookies, JavaScript, or Web Beacons ) may also be used by the third-party ad networks to measure the effectiveness of their advertisements and / or to personalize the advertising content that you see. 

http://mesotheliomacancertreatmentoptions.blogspot.com has no access to or control over these cookies that are used by third-party advertisers. 

You should consult the respective privacy policies of these third-party ad servers for more detailed information on their practices as well as for instructions about how to opt-out of certain practices. http://mesotheliomacancertreatmentoptions.blogspot.com's privacy policy does not apply to, and we cannot control the activities of, such other advertisers or web sites. 

If you wish to disable cookies, you may do so through your individual browser options. More detailed information about cookie management with specific web browsers can be found at the browsers' respective websites. 

Mesothelioma

ABOUT MESOTHELIOMA

Mesothelioma is an asbestos-caused cancer of the membranes that surround many of the body’s vital organs. This membrane, known as mesothelium, secretes a lubricating fluid that provides easy movement of the organs within the body. When the mesothelium becomes cancerous, it is called mesothelioma. Surrounding the lung, the mesothelium is called the pleura and the form of mesothelioma is called pleural mesothelioma; in the abdomen, it is the peritoneum and the cancer is called peritoneal mesothelioma; the lining around the heart is the pericardium and there mesothelioma is identified aspericardial mesothelioma. There is also mesothelial tissue in the reproductive organs: in males, this tissue is called the tunica vaginalis testis and in women the tunica serosa uteri. Mesothelioma of the reproductive tissues has only presented in men, so it is known asmesothelioma of the tunica vaginalis. 

Mesothelioma is a diffuse malignancy and spreads itself throughout a tissue area. Some forms of cancer are characterized by a single, solid tumor mass, whereas malignant mesothelioma presents as an invasion of a large number of smaller masses throughout an entire area. The diffuse nature of mesothelioma has important implications for how mesothelioma is treated, as complete surgical extraction of the cancerous tissue is difficult.

Types of Mesothelioma

There are multiple forms of mesothelioma. The differences involve the location in which the tumor begins, known as its origin site, and the type of cells that the tumor invades, known as its histological subtype.

Location of Disease

The most common form of mesothelioma is pleural mesothelioma, where the cancer attacks the pleural tissue surrounding the lung. As many as eighty percent of all mesothelioma diagnoses are for pleural mesothelioma. The pleura’s proximity to the lung is the reason many people mistakenly think of mesothelioma as lung cancer, which it is not. Pleural mesothelioma can spread (“metastasize”) to the lung, but the origin site is the actual pleural tissue surrounding the lung—not the lung itself. There are manydifferences between mesothelioma and lung caner.

After pleural mesothelioma, the next most common type is peritoneal mesothelioma, which develops in the majority of other cases. There is some evidence to suggest that diagnoses of mesothelioma are on the rise. While pericardial mesothelioma and mesotheliomas of the tunica vaginalis are also possible forms of the disease, they are very rare tumors and occur less often.

Histological Subtype

Besides the location in which the tumors form, the other identifying factor in the diagnosis of mesothelioma is the histological subtype of the cancer. This refers to the type of cells that the tumors invade. There are three histological subtypes of mesothelioma: epithelioid mesothelioma, which attacks epithelial cells, sarcomatoid mesothelioma, which attacks sarcomatous cells, and bi-phasic mesothelioma, where the tumor attacks both epithelial and sarcomatous cells. The identification of the proper subtype is an important diagnostic factor because it greatly affects the disease’s prognosis. Epitheloid mesothelioma has the best response rate for treatment, while sarcomatoid mesothelioma has the worst.